Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial

Abstract Background Definitive concurrent chemoradiotherapy (dCCRT) is the gold standard for the treatment of locally advanced esophageal squamous cell carcinoma (ESCC). However, the potential benefits of consolidation chemotherapy after dCCRT in patients with esophageal cancer remain debatable. Pro...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Chengcheng Fan, Xu Wang, Xiaoli Zheng, Yanan Sun, Ke Ye, Yue Jiang, Xiao Liu, Wencai Xu, Yang Liu, Yuanyuan Yang, Jinsong Liu, Qiong Jiang, Chunyu He, Xiaoyuan Wu, Xin Nie, Jingwei Zhang, Bo Tan, Wen Wang, Yougai Zhang, Zhuo Feng, Chengliang Yang, Yufei Lu, Hailong Liu, Xijuan Chen, Jing Xu, Fang Liu, Xuefeng Zheng, Jianhua Wang, Shang Wu, Guofu Chen, Yaowen Zhang, Linzhi Jin, Hong Ge
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2024-03-01
Seri Bilgileri:	BMC Cancer
Konular:	Esophageal squamous cell carcinoma Consolidation chemotherapy Definitive concurrent chemoradiotherapy
Online Erişim:	https://doi.org/10.1186/s12885-024-12002-5
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!